Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery
Phase 4
Withdrawn
- Conditions
- Glaucoma
- Registration Number
- NCT01229202
- Lead Sponsor
- Nova Scotia Health Authority
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Inclusion Criteria:<br><br> - any type of glaucoma, except neovascular or inflammatory<br><br> - patients requiring trabeculectomy or combined cataract surgery with trabeculectomy<br> surgery<br><br>Exclusion Criteria:<br><br> - younger than 30 years of age<br><br> - previous ocular surgeries excepting cataract surgeries<br><br> - patients who have had or present with intraocular inflammation<br><br> - neovascular glaucoma<br><br> - patients who are aphakic<br><br> - diabetic retinopathy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method post surgery IOP (Intra Ocular Pressure Measurement)
- Secondary Outcome Measures
Name Time Method bleb appearance;number of bleb needlings;number of glaucoma medications at 12 months postoperatively;eye complications;systemic complications;need for another glaucoma surgery to control glaucoma;postoperative visual acuity at 12 months